Drug intelligence / Profile preview

acamprosate

Development stage
Approved
Lead developer
Meram
Modality
Small Molecules
Administration
Oral
01

Overview

Acamprosate is a small molecule drug used to help maintain abstinence in people with alcohol dependence who have already stopped drinking. It is not effective for treating withdrawal symptoms or for individuals who have not ceased alcohol use. Acamprosate acts primarily by modulating and normalizing the balance of neurotransmitters in the brain that are disrupted by chronic alcohol consumption. Its mechanism of action is thought to involve interactions with glutamate (specifically NMDA receptors) and GABA neurotransmitter systems, reducing glutamatergic hyperactivity associated with protracted withdrawal and possibly enhancing GABAergic activity. Structurally, it is an analog of gamma-aminobutyric acid (GABA) and taurine. The drug does not undergo significant metabolism and is excreted mainly via the kidneys[1][3][5][7][10].

Brand names
CampralAotal
Other names
acamprosate calciumN-acetylhomotaurinecalcium acetylhomotaurinate
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)GABA-B (Gamma-aminobutyric acid receptor type B)GRM5 (Metabotropic glutamate receptor 5)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on acamprosate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acamprosate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call